UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition

Hypertension (Dallas, Tex. 1979), 2014-05, Vol.63 (5), p.951-957

2014

Volltextzugriff (PDF)

Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula

Clinical and experimental pharmacology & physiology, 2015-07, Vol.42 (7), p.795-807

2015

Volltextzugriff (PDF)

Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition

Food and chemical toxicology, 2014-06, Vol.68, p.117-127

2014

Volltextzugriff (PDF)

Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide

American Journal of Physiology - Renal Physiology, 2010-11, Vol.299 (5), p.F983-F990

2010

Volltextzugriff (PDF)

Inhibition of in vitro metabolism of testosterone in human, dog and horse liver microsomes to investigate species differences

Toxicology in vitro, 2015-04, Vol.29 (3), p.468-478

2015

Volltextzugriff (PDF)

Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy

Transplantation, 2006-10, Vol.82 (8), p.1108-1111

2006

Volltextzugriff (PDF)

MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

Nature (London), 2014-04, Vol.508 (7495), p.215-221

2014

Volltextzugriff (PDF)

Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

International journal of cancer, 2011-07, Vol.129 (1), p.245-255

2011

Volltextzugriff (PDF)

Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response

Experimental hematology, 2007-10, Vol.35 (10), p.1527-1537

2007

Volltextzugriff (PDF)

Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats

Proceedings of the National Academy of Sciences - PNAS, 2016-03, Vol.113 (13), p.E1796-E1805

2016

Volltextzugriff (PDF)

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Nature (London), 2018-07, Vol.559 (7712), p.125-129

2018

Volltextzugriff (PDF)

Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R)‑1-((S)‑2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy‑N‑(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)

Journal of medicinal chemistry, 2018-01, Vol.61 (2), p.599-618

2018

Volltextzugriff (PDF)

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Journal of medicinal chemistry, 2017-10, Vol.60 (19), p.8011-8026

2017

Volltextzugriff (PDF)

Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events

European journal of cancer (1990), 2021-11, Vol.157, p.474-484

2021

Volltextzugriff (PDF)

Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase

Cancer cell, 2013-09, Vol.24 (3), p.379-393

2013

Volltextzugriff (PDF)

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

Clinical pharmacology and therapeutics, 2011-01, Vol.89 (1), p.65-74

2011

Volltextzugriff (PDF)

PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects

International journal of molecular sciences, 2020-12, Vol.22 (1), p.173

2020

Volltextzugriff (PDF)

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

Proceedings of the National Academy of Sciences - PNAS, 2020-03, Vol.117 (13), p.7374-7381

2020

Volltextzugriff (PDF)

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

Nature (London), 2018-11, Vol.563 (7732), p.564-568

2018

Volltextzugriff (PDF)

Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents

European journal of medicinal chemistry, 2020-01, Vol.186, p.111863, Article 111863

2020

Volltextzugriff (PDF)

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action

Science translational medicine, 2016-10, Vol.8 (362), p.362ps17

2016

Volltextzugriff (PDF)

Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

Cancer cell, 2015-12, Vol.28 (6), p.773-784

2015

Volltextzugriff (PDF)

The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

Leukemia, 2019-10, Vol.33 (10), p.2403-2415

2019

Volltextzugriff (PDF)

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-04, Vol.329 (14), p.1183

2023

Volltextzugriff (PDF)

Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma

Proceedings of the National Academy of Sciences - PNAS, 2017-10, Vol.114 (43), p.11404-11409

2017

Volltextzugriff (PDF)

1 – 25 von 23.895

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Complete Springer Journals

Nur zeigenGeprüft (Peer-Review)

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(20.667)

Publikationsform

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(21.052)
Life Sciences & Biomedicine
(20.110)
Humans
(14.159)
Animals
(13.760)
Male
(12.369)
Biological And Medical Sciences
(10.698)
Enzyme Inhibitors - Pharmacology
(10.587)
Medical Sciences
(7.607)
Middle Aged
(5.807)
Mice
(5.477)
Pharmacology & Pharmacy
(5.171)
Pharmacology. Drug Treatments
(5.096)
Adult
(4.903)
Rats
(4.863)
Aged
(4.106)
Fundamental And Applied Biological Sciences. Psychology
(3.493)
Biochemistry & Molecular Biology
(2.887)
Cardiovascular System & Cardiology
(2.595)
Dose-Response Relationship, Drug
(2.554)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(23.895)
EZB Electronic Journals Library
(12.911)
Ingenta
(11.837)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(10.814)
Elsevier ScienceDirect Journals Complete
(5.957)
IngentaConnect Journals
(5.428)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(5.181)
NUS Single-Journal Subscriptions
(5.028)
Wiley-Blackwell Journals
(4.000)
Wiley Online Library
(3.164)
Oxford Journals
(1.825)
Oxford Journals 2020 Medicine
(1.240)
Nature_系列刊
(1.116)
Taylor & Francis Current Content Access
(755)
Taylor & Francis Journals Auto-Holdings Collection
(692)
Taylor & Francis Online
(686)
Nexis Uni (LexisNexis)
(584)
SAGE Journals【Remote access NOT available】
(396)
JSTOR
(356)
Psychology & Behavioral Sciences Collection
(251)
SpringerLink_现刊
(0)

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition

Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula

Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition

Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide

Inhibition of in vitro metabolism of testosterone in human, dog and horse liver microsomes to investigate species differences

Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy

MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response

Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events

Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action

Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial

Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma

Aktive Filter

Suchergebnisse filtern